Shanghai Haohai Biological Technology (6826.HK) Earnings Analysis

Shanghai Haohai Biological Technology (6826.HK) next reports earnings on 2026-08-22. Trailing P/E 30.95.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 6826.HK next report earnings?

Next earnings date2026-08-22
Consensus EPS estimaten/a
Revenue estimaten/a

6826.HK earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-240.3637 HKDn/an/an/a
2026-02-27-0.30038 HKDn/an/an/a
2025-04-250.4162 HKDn/an/an/a
2025-02-200.2582 HKDn/an/an/a
2024-10-250.3559 HKDn/an/an/a
2024-08-160.877 HKDn/an/an/a

6826.HK valuation and analyst view

Trailing P/E30.95
Trailing EPS1.039 HKD
Price / book1.31
Dividend yield3.17%
Market cap6.63B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Shanghai Haohai Biological Technology (6826.HK)'s next earnings date?

Shanghai Haohai Biological Technology is next scheduled to report on 2026-08-22.

Did 6826.HK beat earnings last quarter?

Consensus estimate data was not available for 6826.HK's 2026-04-24 report.

What is 6826.HK's current P/E ratio and EPS?

6826.HK trades at a trailing P/E of 30.95 on trailing EPS of 1.0385755087183848 HKD.

What do analysts rate 6826.HK?

6826.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.